Naoise Synnott, Ph.D., M.P.H., joined the Integrative Tumor Epidemiology Branch (ITEB) as a Cancer Prevention Fellow in September 2019. Dr. Synnott earned a B.A. (Mod.) in molecular medicine from Trinity College Dublin, Ireland, in 2013 and a Ph.D. in biomedical sciences from the University College Dublin, Ireland, in 2017. Under the mentorship of Professor Michael J. Duffy, her doctoral studies focused on p53 as a therapeutic target in breast cancer. In May 2019, Dr. Synnott earned an M.P.H. from University College Dublin. Dr. Synnott is working with Maria Teresa Landi, Ph.D., M.D., senior investigator, ITEB, to study the etiology of lung cancers. Her work focuses on characterizing the tumor microenvironment using immunohistochemical, immunofluorescent, and digital pathology methods.